Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Hearing Disorders: HELP
Articles by Lizzie Caperon
Based on 1 article published since 2010
(Why 1 article?)
||||

Between 2010 and 2020, Lizzie Caperon wrote the following article about Hearing Disorders.
 
+ Citations + Abstracts
1 Review Patient-Reported Measures of Hearing Loss and Tinnitus in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review. 2016

Stark, Daniel / Rosenberg, Abby R / Johnston, Donna / Knight, Kristin / Caperon, Lizzie / Uleryk, Elizabeth / Frazier, A Lindsay / Sung, Lillian. ·Section of Oncology and Cancer Research, Leeds Institute of Molecular Medicine, University of Leeds, United Kingdom. · Hematology/Oncology, Seattle Children's Hospital, WA. · Division of Paediatric Haematology/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Canada. · Pediatric Audiology, Oregon Health and Science University, Portland. · Scholarly Communications and Researcher Skills, University of Leeds, United Kingdom. · E. M. Uleryk Consulting, Toronto, Ontario, Canada. · Dana-Farber/Boston Children's Cancer Center, MA. · Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada. ·J Speech Lang Hear Res · Pubmed #27603148.

ABSTRACT: Purpose: We identified studies that described use of any patient-reported outcome scale for hearing loss or tinnitus among children and adolescents and young adults (AYAs) with cancer or hematopoietic stem cell transplantation (HSCT) recipients. Method: In this systematic review, we performed electronic searches of OvidSP MEDLINE, EMBASE, and PsycINFO to August 2015. We included studies if they used any patient-reported scale of hearing loss or tinnitus among children and AYAs with cancer or HSCT recipients. Only English language publications were included. Two reviewers identified studies and abstracted data. Results: There were 953 studies screened; 6 met eligibility criteria. All studies administered hearing patient-reported outcomes only once, after therapy completion. None of the studies described the psychometric properties of the hearing-specific component. Three instruments (among 6 studies) were used: Health Utilities Index (Barr et al., 2000; Fu et al., 2006; Kennedy et al., 2014), Hearing Measurement Scales (Einar-Jon et al., 2011; Einarsson et al., 2011), and the Tinnitus Questionnaire for Auditory Brainstem Implant (Soussi & Otto, 1994). All had limitations, precluding routine use for hearing assessment in this population. Conclusions: We identified few studies that included hearing patient-reported measures for children and AYA cancer and HSCT patients. None are ideal to take forward into future studies. Future work should focus on the creation of a new psychometrically sound instrument for hearing outcomes in this population.